Bram De Wilde

4.0k total citations
39 papers, 552 citations indexed

About

Bram De Wilde is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Bram De Wilde has authored 39 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Cancer Research and 14 papers in Neurology. Recurrent topics in Bram De Wilde's work include Neuroblastoma Research and Treatments (14 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Bram De Wilde is often cited by papers focused on Neuroblastoma Research and Treatments (14 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Bram De Wilde collaborates with scholars based in Belgium, Netherlands and United States. Bram De Wilde's co-authors include Katleen De Preter, Jo Vandesompele, Geneviève Laureys, Nele Mahieu, Erik Witvrouw, Ann Cools, Nadine Van Roy, Maurits Boon, Tim Lammens and Ruben Van Paemel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bram De Wilde

37 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bram De Wilde Belgium 14 249 215 125 110 92 39 552
Sarah Fattet France 9 263 1.1× 60 0.3× 56 0.4× 88 0.8× 24 0.3× 14 412
Virginia Di Paolo Italy 12 217 0.9× 138 0.6× 49 0.4× 62 0.6× 19 0.2× 22 372
Laura S. Danielson United States 12 339 1.4× 170 0.8× 119 1.0× 69 0.6× 27 0.3× 24 567
Nobuyuki Kusaka Japan 14 222 0.9× 34 0.2× 48 0.4× 195 1.8× 174 1.9× 27 564
Anna Daroszewska United Kingdom 13 306 1.2× 62 0.3× 28 0.2× 408 3.7× 24 0.3× 22 627
Hidemitsu Kurosawa Japan 14 373 1.5× 69 0.3× 64 0.5× 146 1.3× 63 0.7× 59 827
Micaela Rios Visconti United Kingdom 7 172 0.7× 21 0.1× 38 0.3× 188 1.7× 58 0.6× 8 447
Huajia Zhang United States 10 322 1.3× 64 0.3× 13 0.1× 338 3.1× 58 0.6× 11 766
Dolores Segura Spain 15 249 1.0× 78 0.4× 52 0.4× 67 0.6× 67 0.7× 25 630
Barbara D. Wamil United States 11 107 0.4× 91 0.4× 22 0.2× 94 0.9× 47 0.5× 16 279

Countries citing papers authored by Bram De Wilde

Since Specialization
Citations

This map shows the geographic impact of Bram De Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bram De Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bram De Wilde more than expected).

Fields of papers citing papers by Bram De Wilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bram De Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bram De Wilde. The network helps show where Bram De Wilde may publish in the future.

Co-authorship network of co-authors of Bram De Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of Bram De Wilde. A scholar is included among the top collaborators of Bram De Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bram De Wilde. Bram De Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermeulen, An, Kimberley E. Wever, M. Emmy M. Dolman, et al.. (2025). Second-Generation AURKA-Targeting PROTACs: Structural Optimization toward in Vivo Degradation in Neuroblastoma. Journal of Medicinal Chemistry. 68(22). 23962–23976.
2.
Paemel, Ruben Van, et al.. (2024). A Fast, Affordable, and Minimally Invasive Diagnostic Test for Cancer of Unknown Primary Using DNA Methylation Profiling. Laboratory Investigation. 104(8). 102091–102091. 5 indexed citations
3.
Paemel, Ruben Van, Edward Baert, Liselot Mus, et al.. (2024). Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid. Clinical Epigenetics. 16(1). 87–87. 10 indexed citations
4.
Moreno, Lucas, Pierre Teira, James M. Croop, et al.. (2023). A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors. Frontiers in Pediatrics. 11. 1183295–1183295. 5 indexed citations
5.
Anckaert, Jasper, Anneleen Decock, Kaat Durinck, et al.. (2023). Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
6.
Vloed, Fanny De, Martijn Risseeuw, Jan J. Molenaar, et al.. (2022). Targeted AURKA degradation: Towards new therapeutic agents for neuroblastoma. European Journal of Medicinal Chemistry. 247. 115033–115033. 23 indexed citations
7.
Decock, Anneleen, David Creytens, Steve Lefever, et al.. (2022). mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase. International Journal of Molecular Sciences. 23(19). 11007–11007. 3 indexed citations
8.
Decaesteker, Bieke, et al.. (2022). Cellular senescence in neuroblastoma. British Journal of Cancer. 126(11). 1529–1538. 8 indexed citations
9.
Decaesteker, Bieke, Kaat Durinck, Nadine Van Roy, et al.. (2021). From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. Journal of Personalized Medicine. 11(12). 1286–1286. 2 indexed citations
10.
Awada, Ahmad, Thierry Berghmans, Paul M. Clément, et al.. (2021). Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Critical Reviews in Oncology/Hematology. 169. 103564–103564. 13 indexed citations
11.
Mus, Liselot, Irina Lambertz, Candy Kumps, et al.. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports. 10(1). 218–218. 19 indexed citations
12.
Vandepoele, Karl, Araceli Diez‐Fraile, Katrien Vandemeulebroecke, et al.. (2018). Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing. Pediatric Blood & Cancer. 66(2). e27513–e27513. 5 indexed citations
13.
Roy, Nadine Van, Malaïka Van Der Linden, Björn Menten, et al.. (2017). Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients. Clinical Cancer Research. 23(20). 6305–6314. 81 indexed citations
14.
Wilde, Bram De, Tom Van Maerken, Katleen De Preter, et al.. (2014). Genetisch geïnspireerde toekomstperspectieven voor de therapie van het neuroblastoom. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
15.
Rihani, Ali, Bram De Wilde, Geneviève Laureys, et al.. (2014). CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients. PLoS ONE. 9(12). e114696–e114696. 19 indexed citations
16.
Schulte, Johannes H., Lukas C. Heukamp, Theresa Thor, et al.. (2012). ALK(F1174L) is a driving oncogene of neuroblastoma in transgenic mice. Pediatric Blood & Cancer. 59(6). 989–989. 1 indexed citations
17.
Coppieters, Frauke, Bram De Wilde, Steve Lefever, et al.. (2012). Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis. Genetics in Medicine. 14(6). 576–585. 33 indexed citations
18.
Vergult, Sarah, A. Jeannette M. Hoogeboom, Emilia K. Bijlsma, et al.. (2012). Complex genetics of radial ray deficiencies: screening of a cohort of 54 patients. Genetics in Medicine. 15(3). 195–202. 22 indexed citations
19.
Leeneer, Kim De, Joachim De Schrijver, Lieven Clement, et al.. (2011). Practical Tools to Implement Massive Parallel Pyrosequencing of PCR Products in Next Generation Molecular Diagnostics. PLoS ONE. 6(9). e25531–e25531. 34 indexed citations
20.
Mahieu, Nele, Ann Cools, Bram De Wilde, Maurits Boon, & Erik Witvrouw. (2009). Effect of proprioceptive neuromuscular facilitation stretching on the plantar flexor muscle‐tendon tissue properties. Scandinavian Journal of Medicine and Science in Sports. 19(4). 553–560. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Fattet Breakdown of academic impact, for papers by Virginia Di Paolo Breakdown of academic impact, for papers by Laura S. Danielson Breakdown of academic impact, for papers by Nobuyuki Kusaka Breakdown of academic impact, for papers by Anna Daroszewska Breakdown of academic impact, for papers by Hidemitsu Kurosawa Breakdown of academic impact, for papers by Micaela Rios Visconti Breakdown of academic impact, for papers by Huajia Zhang Breakdown of academic impact, for papers by Dolores Segura Breakdown of academic impact, for papers by Barbara D. Wamil
Rankless by CCL
2026